Energy Transfer in CeTbF Nanoparticles-CTAB Shell-Chlorin e System.

Formation and electronic excitation energy transfer process in the nanosystem consisting of CeTbF nanoparticles, cetrimonium bromide (CTAB) surfactant, and chlorin e photosensitizer were studied. It was shown that chlorin e molecules bind to CeTbF NP in the presence of CTAB forming thus CeTbF NP-CTAB-chlorin e nanosystem. We consider that binding occurs via chlorin e embedding in the shell of CTAB molecules, formed around NP.

Chlorin e6 combined with albumin nanoparticles as a potential composite photosensitizer for photodynamic therapy of tumors.

Aim: To synthesize and to study for photodynamic activity a composite photosensitizer consisting of chlorin e6 and human serum albumin nanoparticles (HSA NPs).

Materials And Methods: Starting from sorption-purified HSA, the albumin nanoparticles with a different degree of lysine residues cross-linking (10; 20; 40, and 100%) were obtained by the coacervation method. The HSA NPs were used for synthesis of nanocomposites with chlorin e6 and fluorescein isothiocyanate (FITC)-labeled preparations.

Gold mining for PDT: Great expectations from tiny nanoparticles.

Among many and various products, born by the modern nanotechnology, gold nanoparticles roused a special interest of biomedical researchers. Unique features of the nanoparticles allow to use them not only as effective transporters for therapeutic agents but also as basic components of nanocomposite preparations intended for targeted photodynamic and photothermal therapy of tumours. In the review, physical, chemical and biological properties of gold nanoparticles which can promote PDT efficiency of a designed nanocomposite, are briefly characterized, and promising trends in creation of gold-containing composite photosensitizers are analysed.

Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype.

Unlabelled: Photodynamic therapy (PDT) is considered as a possible alternative approach to overcoming multidrug resistance (MDR). Analysis of cross-resistance to PDT in cells with different MDR pathways and resistance levels seems to be advantageous for elucidating the general mechanisms of cancer cell resistance to various treatment modalities.

Aim: The aim of the study was to clarify whether the Jurkat/A4 leukemia cells with MDR phenotype are cross-resistant to PDT.

Chronobiological approaches to antiangiogenic photodynamic therapy of tumors: the first experimental evaluation.

Unlabelled: In research of the last decade, rhythmic (circadian) variations of vascular endothelial growth factor (VEGF) production by tumors were discovered. The present paper authors have earlier synthesized and characterized a new derivative photosensitizer - an immunoconjugate of hematoporphyrin with antiVEGF antibodies.

Aim: To elaborate and to test a novel modification of the photodynamic therapy of tumors (PDT) method, founding upon a timed introduction of the immunoconjugated photosensitizer to tumor-bearing animals, so that this coincides with a maximum content of VEGF in tumor tissues.